Alzheimer's News Today

Home
United States
Dallas, TX
Alzheimer's News Today

We are dedicated to sharing the latest news, research, and Alzheimer’s disease patient perspectives.

09/08/2025

The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early Alzheimer's disease https://buff.ly/ZmMy3tH

09/05/2025

September is World Alzheimer's Month, and advocates aim to focus on fighting the stigma surrounding dementia. https://buff.ly/lwHiQR2

08/01/2025

Blarcamesine appeared to slow the decline of cognition and functional capacity for people with Alzheimer’s disease in a long-term trial. https://alzheimersnewstoday.com/news/blarcamesine-works-better-taken-earlier-alzheimers-study/

07/11/2025

A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug Administration. https://alzheimersnewstoday.com/news/fda-approves-new-kisunla-dosing-regimen-lower-aria-e-risk/

06/06/2025

The Alzheimer's Association is urging patients, caregivers, and advocates to "take action now" and support legislation this awareness month. https://buff.ly/ZKZOeFJ

05/02/2025

The new ApoE4 Alzheimer's Alliance plans to advocate on behalf of patients with this gene variant for more supportive U.S. policies. https://buff.ly/e12Q0yK

04/21/2025

Leqembi has been approved in the European Union for the treatment of certain adults with early Alzheimer's disease and mild cognitive issues. https://buff.ly/AjWn0ab

04/04/2025

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily function. https://buff.ly/Tt1gtM9

03/07/2025

Early menopause and poor brain-connection health may interact to increase Alzheimer's disease risk in women, a study found. https://buff.ly/qSvMAdJ

02/07/2025

The U.S. FDA has approved monthly maintenance dosing for Leqembi, a treatment for early Alzheimer’s disease. https://buff.ly/3Q8mCOs

01/03/2025

The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ADVANCE-2 didn't. https://bit.ly/3W4Heu2

12/09/2024

While columnist Ray Burow loves the Christmas season, she had to alter her expectations for it when she was an Alzheimer's caregiver. https://bit.ly/3OM6bGU

Address

5307 E Mockingbird Lane
Dallas, TX
75206

Telephone

+18009361363

Website

http://alzheimersnewstoday.com/

Alerts

Be the first to know and let us send you an email when Alzheimer's News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Media Company in Dallas?